Search

The article examines how parallel trade affects drug policies and prices in Canada and the U.S. U.S. consumers and Canadian pharmacies have taken advantage of the opportunity presented by price differences in patented pharmaceuticals. This brought the Canadian and U.S. systems for determining pharmaceutical pricing under increased scrutiny. It asserts that the price discrimination strategies of pharmaceutical manufacturers and exchange rate fluctuate have played an underappreciated role.